Medical Product Alerts
The World Health Organization's Medical Product Alerts are designed to warn Member States and populations of the existence of dangerous medical products and encourage increased vigilance and appropriate regulatory action by National Medicines Regulatory Authorities/ Ministries of Health to protect populations and supply chains.
Read WHO news alert calling for action to protect children from contaminated medicines
Please see below for the latest WHO Medical Product Alerts:
Alert N°7/2023 - Falsified DEFITELIO (defibrotide) identified in the WHO Regions of Europe and South-East Asia
Alert N°6/2023 - Substandard (contaminated) syrup medicines identified in WHO Region of the Eastern Mediterranean
Alert N°5/2023 - Substandard (contaminated) syrup medicines identified in WHO Region of Africa
Alert N°4/2023 - Substandard (contaminated) syrup medicines identified in WHO Region of the Western Pacific
Alert N°3/2023 - Falsified DEFITELIO (defibrotide sodium) identified in the WHO Regions of Europe and the Eastern Mediterranean
Alert N°2/2023 - Tetracycline Hydrochloride Ophthalmic Ointment USP 1%
Alert N°1/2023 - Substandard (contaminated) liquid dosage medicines identified in WHO European Region
Alert N°8/2022 - Substandard (contaminated) METHOTREX 50mg CRM:0402908
Alert N°7/2022 - Substandard (contaminated) paediatric liquid dosage medicines identified in WHO region of South-East Asia
Alert N°6/2022 - Substandard (contaminated) paediatric medicines identified in WHO region of Africa
Alert N°5/2022 - Falsified DIPRIVAN (Propofol) identified in WHO region of the Americas
Alert N°4/2022 - the Falsified Dysport identified in the WHO Regions of Europe and Eastern Mediterranean
Alert N°3/2022 - Falsified Intratect (Human normal immunoglobulin) identified in the WHO Regions of the Americas, Eastern Mediterranean and South-East Asia
Alert N°2/2022 - Falsified DESREM (Remdesivir) identified in the WHO Regions of the Americas and South-East Asia
Alert N° 9/2021 - Falsified Soliris identified in WHO regions of the Americas, Europe and South East Asia
Alert N° 8/2021 - Falsified Combiart identified in WHO region of Africa
Alert N° 7/2021 - Falsified COVID-19 VACCINE AstraZeneca identified in WHO region of the Eastern Mediterranean
Alert N° 6/2021 - Falsified Pfizer-BioNTech COVID-19 Vaccine identified in WHO region of the Eastern Mediterranean
Alert N° 5/2021 - Falsified COVISHIELD vaccine identified in the WHO regions of Africa and South- East Asia
Alert N° 4/2021 - Falsified Remdesivir identified in WHO region of the Americas
Alert N° 3/2021 - Falsified CYTOTEC identified in WHO region of Africa
Alert N° 2/2021 - Falsified COVID-19 Vaccine BNT162b2 identified in the WHO region of the Americas
Alert N°1/2021 - Falsified VITAMIN A (retinol) identified in WHO region of Africa
Alert N°7/2020 - Falsified HARVONI (Ledipasvir/sofosbuvir) identified in the WHO regions of the Americas and Europe
Alert N° 6/2020 - Falsified Fluzone® Quadrivalent Influenza Vaccine identified in WHO region of the Americas
Alert N° 5/2020 - Falsified and contaminated Defibrotide identified in WHO regions of Western Pacific, Europe and Eastern Mediterranean
Alert N°4/2020 - Falsified chloroquine products circulating in the WHO regions of Africa and Europe
Alert N° 3/2020 - Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19
Alert N° 2/2020 - Falsified HIV rapid diagnostic test circulating in the WHO regions of the Americas and Africa
Alert N°1/2020 - Falsified antimalarials in Nigeria, Cameroon and Chad
Alert N°11/2019 - Falsified Amoxicillin + Clavulanic Acid products circulating in Haiti
Alert N°10/2019 - Falsified Quinine Bisulphate circulating in Uganda and Quinine Sulphate circulating in Central African Republic and Chad
Alert N°9/2019 - Falsified Augmentin found in Uganda and Kenya
Alert N° 8/2019 - Falsified Rabies Vaccines and Anti-Rabies Serum circulating in the Philippines
Alert N° 7/2019 - Falsified meglumine antimoniate ampoules in Iran and Pakistan
Alert N°6/2019 - Falsified hydrochlorothiazide (containing glibenclamide) in Cameroon
Alert N°5/2019 - Falsified meningitis vaccines circulating in Niger
Alert N°4/2019 - Falsified oral cholera vaccines circulating in Bangladesh
Alert N° 3/2019 - Falsified ICLUSIG available at patient level in Asia and traded globally
Alert N° 2/2019 - Falsified ICLUSIG traded globally
Alert N° 1/2019 - Falsified Rabies Vaccines circulating in the Philippines
Alert N° 3/2018 - Falsified Hepatitis B Vaccines circulating in Uganda
Alert N° 2/2018 - Falsified “Augmentin” circulating in Cameroon
Alert N° 1/2018 - Falsified cefixime products circulating in the Democratic Republic of the Congo
Alert N° 4/2017 - Falsified Penicillin V circulating in Cameroon
Alert N° 3/2017 - Falsified Avastin (bevacizumab) and Sutent (sunitinib malate) circulating in East Africa
Alert N° 2/2017 - Falsified Quinine Sulphate circulating in Africa
Alert N° 1/2017 - Falsified Meningococcal ACWY Vaccine circulating in West Africa
Alert N° 4/2016: Quinine Sulphate - Falsified Quinine Sulphate circulating in West and Central Africa
Alert N° 3/2016: LEDSO capsules, DAKAVIR - Falsified Hepatitis C medicines circulating in South East Asia
Alert N° 2/2016: AMARIL - Falsified "AMARIL" yellow fever vaccines circulating in South East Asia
Alert N° 1/2016: Phenobarbitone - Falsified phenobarbitone tablets circulating in West Africa
For further information on Medical Product Alerts, please visit the WHO website (link is external).
Visit our 'Useful resources' page for details of organisations involved in tackling the global problem of falsified and substandard medicines.